Physitrack Second Quarter 2025 Earnings: €0.01 loss per share (vs €0.029 loss in 2Q 2024)

Physitrack (STO:PTRK) Second Quarter 2025 Results

Key Financial Results

• Revenue: €3.51m (down 11% from 2Q 2024).
• Net loss: €150.4k (loss narrowed by 68% from 2Q 2024).
• €0.01 loss per share (improved from €0.029 loss in 2Q 2024).

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Physitrack Earnings Insights

Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Healthcare Services industry in Sweden.

Performance of the Swedish Healthcare Services industry.

The company's shares are up 1.4% from a week ago.

Risk Analysis

You should learn about the 2 warning signs we've spotted with Physitrack (including 1 which is concerning).

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.